- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
B-K releases scanners, transducers
The Denmark-based subsidiary of Analogic, B-K Medical, exhibited several new ultrasound technologies at the American College of Surgeons Annual Clinical Congress in October. Topping the introductions were the Hawk 2102 EXL color scanner, the company's
The Denmark-based subsidiary of Analogic, B-K Medical, exhibited several new ultrasound technologies at the American College of Surgeons Annual Clinical Congress in October. Topping the introductions were the Hawk 2102 EXL color scanner, the company's new flagship ultrasound scanner, and the new black-and-white Falcon 2101 EXL. Both incorporate advanced focusing and proprietary detector technology, large monitors, sophisticated video interface, and fully integrated 3D option. The Hawk also boasts improved Doppler functionality. Vascular scanning is enhanced by a new, dedicated transducer, dubbed type 8812, which combines deep Doppler sensitivity with near-field performance. The company also showed a new transducer optimized for breast and musculoskeletal scanning. The probe, which works with B-K's portable Merlin 1101, is pending FDA clearance for musculoskeletal applications.
Two weeks after the conference, the company announced the resignation of Rene Barington as its managing director. Barington held the post for six years.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
